BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 24169396)

  • 1. Solid neuroendocrine carcinoma of the breast.
    Abbasi NZ; Zahur Z; Sheikh AS; Khan AA; Ali F; Memon KH; Moizuddin SS; Loya A; Barkat N
    J Coll Physicians Surg Pak; 2013 Nov; 23(10):820-2. PubMed ID: 24169396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine carcinoma of the breast--diagnostic and clinical implications.
    Watrowski R; Jäger C; Mattern D; Horst C
    Anticancer Res; 2012 Nov; 32(11):5079-82. PubMed ID: 23155283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine carcinomas of the breast.
    Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
    Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine breast tumours: breast cancer or neuroendocrine cancer presenting in the breast?
    Adams RW; Dyson P; Barthelmes L
    Breast; 2014 Apr; 23(2):120-7. PubMed ID: 24342375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of cytokeratin 20-positive large-cell neuroendocrine carcinoma of the breast.
    Okoshi K; Saiga T; Hisamori S; Iwaisako K; Kobayashi H; Ogawa H
    Breast Cancer; 2012 Oct; 19(4):360-4. PubMed ID: 19669861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Primary neuroendocrine tumors of the breast: a retrospective study of 21 cases and literature review].
    Feki J; Fourati N; Mnif H; Khabir A; Toumi N; Khanfir A; Boudawara T; Amouri H; Daoud J; Frikha M
    Cancer Radiother; 2015 Aug; 19(5):308-12. PubMed ID: 26215367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine Tumors of the Breast.
    Rosen LE; Gattuso P
    Arch Pathol Lab Med; 2017 Nov; 141(11):1577-1581. PubMed ID: 29072945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine carcinoma of the breast: a rare entity].
    Sartori A; Scomersi S; Spivach A; Vigna S
    Chir Ital; 2009; 61(2):265-7. PubMed ID: 19537005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral primary breast neuroendocrine carcinoma in a young woman: report of a case.
    Zhang JY; Chen WJ
    Surg Today; 2011 Nov; 41(11):1575-8. PubMed ID: 21969166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of primary neuroendocrine breast carcinoma that responded to neo-adjuvant chemotherapy.
    Wei X; Chen C; Xi D; Bai J; Huang W; Rong L; Wu M; Zhang G
    Front Med; 2015 Mar; 9(1):112-6. PubMed ID: 25098433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
    Tang F; Wei B; Tian Z; Gilcrease MZ; Huo L; Albarracin CT; Resetkova E; Zhang H; Sahin A; Chen J; Bu H; Abraham S; Wu Y
    Histopathology; 2011 Jul; 59(1):106-15. PubMed ID: 21668471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of neuroendocrine differentiated breast carcinoma.
    Berruti A; Saini A; Leonardo E; Cappia S; Borasio P; Dogliotti L
    Breast; 2004 Dec; 13(6):527-9. PubMed ID: 15563864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical studies of pulmonary large cell neuroendocrine carcinoma: a possible association between staining patterns with neuroendocrine markers and tumor response to chemotherapy.
    Tanaka Y; Ogawa H; Uchino K; Ohbayashi C; Maniwa Y; Nishio W; Nakao A; Yoshimura M
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):839-46. PubMed ID: 22498090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of changes of biologic markers ER, PR, HER 2 and Ki-67 in breast cancer with administration of neoadjuvant dose-dense doxorubicin, cyclophosphamide followed by paclitaxel.
    Dede DS; Gumuskaya B; Guler G; Onat D; Altundag K; Ozisik Y
    J BUON; 2013; 18(1):57-63. PubMed ID: 23613389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and treatment response of solid neuroendocrine breast carcinoma to adjuvant chemotherapy and endocrine therapy.
    Zhu Y; Li Q; Gao J; He Z; Sun R; Shen G; Zhang H; Xia W; Xu J
    Breast J; 2013; 19(4):382-7. PubMed ID: 23721399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large cell neuroendocrine carcinoma of the lung: what we have to do.
    Filosso PL
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1182-3; author reply 1183-4. PubMed ID: 12771909
    [No Abstract]   [Full Text] [Related]  

  • 17. Breast conservation in patients with multiple ipsilateral synchronous cancers.
    Kaplan J; Giron G; Tartter PI; Bleiweiss IJ; Estabrook A; Smith SR
    J Am Coll Surg; 2003 Nov; 197(5):726-9. PubMed ID: 14585405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine Carcinoma of the Breast: Current Evidence and Future Perspectives.
    Inno A; Bogina G; Turazza M; Bortesi L; Duranti S; Massocco A; Zamboni G; Carbognin G; Alongi F; Salgarello M; Gori S
    Oncologist; 2016 Jan; 21(1):28-32. PubMed ID: 26659223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroendocrine carcinoma of the breast - a pilot study of a Danish population of 240 breast cancer patients.
    Brask JB; Talman ML; Wielenga VT
    APMIS; 2014 Jul; 122(7):585-92. PubMed ID: 24320610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary neuroendocrine tumors of the breast: two case reports and review of the literature.
    Hejjane L; Oualla K; Bouchbika Z; Bourhafour M; Lhlou Mimi A; Boubacar E; Benider A; Benbrahim Z; Aarifi S; Mellas N
    J Med Case Rep; 2020 Mar; 14(1):41. PubMed ID: 32156307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.